A new national survey by the Orlando Health Cancer Institute finds nearly a third (32%) of Americans agree that a tan makes people look better and healthier, a dangerous beauty standard that experts say can lead to risky behavior when it comes to sun exposure.
After first-line approval in DLBCL, debate continues around benefit from Roche’s ADC Polivy
The FDA approved Roche and Genentech’s antibody-drug conjugate Polivy in April as a first-line treatment for diffuse large B-cell lymphoma (DLBCL) alongside a chemotherapy regimen
August 25, 2023